A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

EKKDA Announces Sales-Distribution Agreement with OCuSOFT Inc.

EKKDA Research, LLC, an ophthalmic-focused research and development company based in Kingsland, Texas is pleased to announce a sales-distribution agreement has been reached with OCuSOFT Inc.

Stacy Foster, EKKDA’s Chairman and the former Chief Business Officer for OCuSOFT®, made the announcement today.

According to Mr. Foster, given the established ophthalmic relationships both in ophthalmology and optometry, EKKDA’s research projects will be focused primarily on eye care.  There are, however, other opportunities in various fields including dermatology, urology, and neurology to name a few. The greater Austin area has become a hotbed of innovation in both technology and medicine according to Mr. Foster.  He also states, “Some of the early projects EKKDA is working on will be quicker to market so having a sales, marketing, and distribution partner like OCuSOFT® is a real plus. They have the respect of the eye care community with a long track record of service. I should know I spent 11 years with the company”.  Mr. Foster goes on to say that further announcements relating to projects underway will be made in due course.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy